Annual EBITDA
$25.82 M
+$62.20 M+170.99%
30 June 2024
Summary:
MEI Pharma annual earnings before interest, taxes, depreciation & amortization is currently $25.82 million, with the most recent change of +$62.20 million (+170.99%) on 30 June 2024. During the last 3 years, it has risen by +$85.96 million (+142.94%). MEIP annual EBITDA is now at all-time high.MEIP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$7.98 M
-$28.00 K-0.35%
30 September 2024
Summary:
MEI Pharma quarterly earnings before interest, taxes, depreciation & amortization is currently -$7.98 million, with the most recent change of -$28.00 thousand (-0.35%) on 30 September 2024. Over the past year, it has dropped by -$63.35 million (-114.42%). MEIP quarterly EBITDA is now -114.42% below its all-time high of $55.37 million, reached on 30 September 2023.MEIP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$37.53 M
-$63.35 M-245.32%
30 September 2024
Summary:
MEI Pharma TTM earnings before interest, taxes, depreciation & amortization is currently -$37.53 million, with the most recent change of -$63.35 million (-245.32%) on 30 September 2024. Over the past year, it has dropped by -$74.64 million (-201.13%). MEIP TTM EBITDA is now -201.13% below its all-time high of $37.11 million, reached on 30 September 2023.MEIP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MEIP EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +171.0% | -114.4% | -201.1% |
| 3 y3 years | +142.9% | +60.1% | +44.4% |
| 5 y5 years | +155.9% | +36.6% | +23.0% |
MEIP EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +134.4% | -114.4% | +62.8% | -201.1% | +50.1% |
| 5 y | 5 years | at high | +134.4% | -114.4% | +62.8% | -201.1% | +50.1% |
| alltime | all time | at high | +134.4% | -114.4% | +62.8% | -201.1% | +50.1% |
MEI Pharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.98 M(+0.4%) | -$37.53 M(-245.3%) |
| June 2024 | $25.82 M(-171.0%) | -$7.96 M(-18.3%) | $25.82 M(+13.3%) |
| Mar 2024 | - | -$9.74 M(-17.7%) | $22.80 M(+40.3%) |
| Dec 2023 | - | -$11.85 M(-121.4%) | $16.25 M(-56.2%) |
| Sept 2023 | - | $55.37 M(-604.2%) | $37.11 M(-202.0%) |
| June 2023 | -$36.38 M(-51.6%) | -$10.98 M(-32.6%) | -$36.38 M(-12.4%) |
| Mar 2023 | - | -$16.29 M(-280.7%) | -$41.51 M(-11.1%) |
| Dec 2022 | - | $9.02 M(-149.8%) | -$46.68 M(-36.3%) |
| Sept 2022 | - | -$18.12 M(+12.5%) | -$73.25 M(-2.5%) |
| June 2022 | -$75.16 M(+25.0%) | -$16.11 M(-25.0%) | -$75.16 M(+0.9%) |
| Mar 2022 | - | -$21.47 M(+22.3%) | -$74.45 M(+7.4%) |
| Dec 2021 | - | -$17.55 M(-12.4%) | -$69.31 M(+2.7%) |
| Sept 2021 | - | -$20.03 M(+30.0%) | -$67.45 M(+12.2%) |
| June 2021 | -$60.14 M(+135.0%) | -$15.40 M(-5.6%) | -$60.14 M(+80.9%) |
| Mar 2021 | - | -$16.32 M(+4.0%) | -$33.24 M(+13.3%) |
| Dec 2020 | - | -$15.70 M(+23.5%) | -$29.33 M(+14.1%) |
| Sept 2020 | - | -$12.71 M(-210.6%) | -$25.71 M(+0.5%) |
| June 2020 | -$25.59 M(-44.6%) | $11.50 M(-192.6%) | -$25.59 M(-47.6%) |
| Mar 2020 | - | -$12.41 M(+2.8%) | -$48.80 M(-0.4%) |
| Dec 2019 | - | -$12.08 M(-4.1%) | -$48.98 M(+0.5%) |
| Sept 2019 | - | -$12.59 M(+7.4%) | -$48.74 M(+5.6%) |
| June 2019 | -$46.16 M(+61.8%) | -$11.72 M(-6.9%) | -$46.16 M(+10.2%) |
| Mar 2019 | - | -$12.59 M(+6.4%) | -$41.91 M(+18.5%) |
| Dec 2018 | - | -$11.83 M(+18.1%) | -$35.35 M(+19.1%) |
| Sept 2018 | - | -$10.02 M(+34.3%) | -$29.68 M(+4.0%) |
| June 2018 | -$28.53 M(-1255.7%) | -$7.46 M(+23.5%) | -$28.53 M(+12.0%) |
| Mar 2018 | - | -$6.04 M(-1.9%) | -$25.47 M(+26.8%) |
| Dec 2017 | - | -$6.16 M(-30.6%) | -$20.08 M(+859.1%) |
| Sept 2017 | - | -$8.87 M(+101.9%) | -$2.09 M(-184.8%) |
| June 2017 | $2.47 M(-111.8%) | -$4.39 M(+568.9%) | $2.47 M(+133.8%) |
| Mar 2017 | - | -$657.00 K(-105.6%) | $1.06 M(-128.7%) |
| Dec 2016 | - | $11.83 M(-374.5%) | -$3.68 M(-82.1%) |
| Sept 2016 | - | -$4.31 M(-25.8%) | -$20.63 M(-1.5%) |
| June 2016 | -$20.95 M(-36.0%) | -$5.81 M(+7.7%) | -$20.95 M(+0.7%) |
| Mar 2016 | - | -$5.39 M(+5.5%) | -$20.81 M(-14.6%) |
| Dec 2015 | - | -$5.11 M(+10.4%) | -$24.36 M(-14.1%) |
| Sept 2015 | - | -$4.63 M(-18.4%) | -$28.35 M(-13.3%) |
| June 2015 | -$32.71 M(+20.3%) | -$5.67 M(-36.6%) | -$32.71 M(-8.1%) |
| Mar 2015 | - | -$8.94 M(-1.8%) | -$35.58 M(+4.5%) |
| Dec 2014 | - | -$9.10 M(+1.3%) | -$34.03 M(+8.8%) |
| Sept 2014 | - | -$8.99 M(+5.2%) | -$31.27 M(+15.0%) |
| June 2014 | -$27.18 M | -$8.54 M(+15.5%) | -$27.18 M(+24.4%) |
| Mar 2014 | - | -$7.40 M(+16.7%) | -$21.85 M(+27.0%) |
| Dec 2013 | - | -$6.34 M(+29.3%) | -$17.21 M(+26.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2013 | - | -$4.90 M(+52.2%) | -$13.62 M(+21.8%) |
| June 2013 | -$11.18 M(+33.4%) | -$3.22 M(+16.9%) | -$11.18 M(+10.0%) |
| Mar 2013 | - | -$2.75 M(+0.3%) | -$10.16 M(+4.7%) |
| Dec 2012 | - | -$2.75 M(+11.7%) | -$9.70 M(+8.9%) |
| Sept 2012 | - | -$2.46 M(+11.7%) | -$8.91 M(+16.3%) |
| June 2012 | -$8.38 M(+30.2%) | -$2.20 M(-4.3%) | -$7.66 M(+13.2%) |
| Mar 2012 | - | -$2.30 M(+17.7%) | -$6.77 M(+17.1%) |
| Dec 2011 | - | -$1.95 M(+61.3%) | -$5.78 M(-1.9%) |
| Sept 2011 | - | -$1.21 M(-7.5%) | -$5.89 M(-8.5%) |
| June 2011 | -$6.44 M(-19.3%) | -$1.31 M(+0.1%) | -$6.44 M(-7.8%) |
| Mar 2011 | - | -$1.31 M(-36.7%) | -$6.99 M(-11.7%) |
| Dec 2010 | - | -$2.06 M(+17.6%) | -$7.91 M(+8.3%) |
| Sept 2010 | - | -$1.76 M(-5.4%) | -$7.30 M(-8.2%) |
| June 2010 | -$7.98 M(-28.6%) | -$1.86 M(-16.8%) | -$7.95 M(-31.0%) |
| Mar 2010 | - | -$2.23 M(+53.3%) | -$11.52 M(+2.9%) |
| Dec 2009 | - | -$1.46 M(-39.5%) | -$11.19 M(-1.3%) |
| Sept 2009 | - | -$2.41 M(-55.6%) | -$11.34 M(+1.4%) |
| June 2009 | -$11.18 M(-14.5%) | -$5.42 M(+184.9%) | -$11.18 M(+13.7%) |
| Mar 2009 | - | -$1.90 M(+19.1%) | -$9.83 M(-12.7%) |
| Dec 2008 | - | -$1.60 M(-29.0%) | -$11.26 M(-5.9%) |
| Sept 2008 | - | -$2.25 M(-44.8%) | -$11.97 M(-8.5%) |
| June 2008 | -$13.08 M(-5.3%) | -$4.08 M(+22.3%) | -$13.08 M(+18.4%) |
| Mar 2008 | - | -$3.33 M(+44.2%) | -$11.05 M(+17.0%) |
| Dec 2007 | - | -$2.31 M(-31.4%) | -$9.44 M(+1.5%) |
| Sept 2007 | - | -$3.37 M(+64.8%) | -$9.30 M(-32.7%) |
| June 2007 | -$13.82 M(+87.1%) | -$2.04 M(+18.6%) | -$13.82 M(+12.1%) |
| Mar 2007 | - | -$1.72 M(-20.8%) | -$12.33 M(-11.0%) |
| Dec 2006 | - | -$2.17 M(-72.4%) | -$13.86 M(+2.9%) |
| Sept 2006 | - | -$7.88 M(+1327.5%) | -$13.46 M(+82.3%) |
| June 2006 | -$7.38 M(+15.0%) | -$552.00 K(-83.0%) | -$7.38 M(-17.1%) |
| Mar 2006 | - | -$3.25 M(+82.9%) | -$8.91 M(+20.4%) |
| Dec 2005 | - | -$1.78 M(-1.4%) | -$7.40 M(+5.8%) |
| Sept 2005 | - | -$1.80 M(-13.2%) | -$6.99 M(+8.9%) |
| June 2005 | -$6.42 M(-24.8%) | -$2.08 M(+19.3%) | -$6.42 M(+15.8%) |
| Mar 2005 | - | -$1.74 M(+26.5%) | -$5.55 M(+3.7%) |
| Dec 2004 | - | -$1.38 M(+11.8%) | -$5.35 M(-38.2%) |
| Sept 2004 | - | -$1.23 M(+2.4%) | -$8.65 M(+1.4%) |
| June 2004 | -$8.54 M(+181.5%) | -$1.20 M(-22.1%) | -$8.54 M(+0.2%) |
| Mar 2004 | - | -$1.54 M(-67.1%) | -$8.52 M(+12.5%) |
| Dec 2003 | - | -$4.68 M(+320.3%) | -$7.58 M(+161.6%) |
| Sept 2003 | - | -$1.11 M(-6.1%) | -$2.90 M(+62.4%) |
| June 2003 | -$3.03 M(+2386.1%) | -$1.19 M(+98.8%) | -$1.78 M(+198.8%) |
| Mar 2003 | - | -$597.00 K | -$597.00 K |
| June 2002 | -$122.00 K | - | - |
FAQ
- What is MEI Pharma annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for MEI Pharma?
- What is MEI Pharma annual EBITDA year-on-year change?
- What is MEI Pharma quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for MEI Pharma?
- What is MEI Pharma quarterly EBITDA year-on-year change?
- What is MEI Pharma TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for MEI Pharma?
- What is MEI Pharma TTM EBITDA year-on-year change?
What is MEI Pharma annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of MEIP is $25.82 M
What is the all time high annual EBITDA for MEI Pharma?
MEI Pharma all-time high annual earnings before interest, taxes, depreciation & amortization is $25.82 M
What is MEI Pharma annual EBITDA year-on-year change?
Over the past year, MEIP annual earnings before interest, taxes, depreciation & amortization has changed by +$62.20 M (+170.99%)
What is MEI Pharma quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of MEIP is -$7.98 M
What is the all time high quarterly EBITDA for MEI Pharma?
MEI Pharma all-time high quarterly earnings before interest, taxes, depreciation & amortization is $55.37 M
What is MEI Pharma quarterly EBITDA year-on-year change?
Over the past year, MEIP quarterly earnings before interest, taxes, depreciation & amortization has changed by -$63.35 M (-114.42%)
What is MEI Pharma TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of MEIP is -$37.53 M
What is the all time high TTM EBITDA for MEI Pharma?
MEI Pharma all-time high TTM earnings before interest, taxes, depreciation & amortization is $37.11 M
What is MEI Pharma TTM EBITDA year-on-year change?
Over the past year, MEIP TTM earnings before interest, taxes, depreciation & amortization has changed by -$74.64 M (-201.13%)